vs
Side-by-side financial comparison of MARA Holdings, Inc. (MARA) and Bio-Techne (TECH). Click either name above to swap in a different company.
Bio-Techne is the larger business by last-quarter revenue ($295.9M vs $202.3M, roughly 1.5× MARA Holdings, Inc.). Bio-Techne runs the higher net margin — 12.8% vs -14298.3%, a 14311.1% gap on every dollar of revenue. On growth, MARA Holdings, Inc. posted the faster year-over-year revenue change (-5.6% vs -6.4%). Over the past eight quarters, MARA Holdings, Inc.'s revenue compounded faster (10.7% CAGR vs 4.2%).
MARA Holdings, Inc. is an American digital asset technology and cryptocurrency mining company headquartered in Fort Lauderdale, Florida. Founded in 2010, the company initially operated as a patent holding company before pivoting in the late 2010s to focus on blockchain infrastructure and digital assets.
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
MARA vs TECH — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $202.3M | $295.9M |
| Net Profit | $-1.7B | $38.0M |
| Gross Margin | — | 64.6% |
| Operating Margin | -11795.9% | 18.4% |
| Net Margin | -14298.3% | 12.8% |
| Revenue YoY | -5.6% | -6.4% |
| Net Profit YoY | -423.5% | 68.3% |
| EPS (diluted) | $-4.25 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $202.3M | $295.9M | ||
| Q3 25 | $252.4M | — | ||
| Q2 25 | $238.5M | $317.0M | ||
| Q1 25 | $213.9M | $316.2M | ||
| Q4 24 | $214.4M | $297.0M | ||
| Q3 24 | $131.6M | $289.5M | ||
| Q2 24 | $145.1M | $306.1M | ||
| Q1 24 | $165.2M | $303.4M |
| Q4 25 | $-1.7B | $38.0M | ||
| Q3 25 | $123.1M | — | ||
| Q2 25 | $808.2M | $-17.7M | ||
| Q1 25 | $-533.4M | $22.6M | ||
| Q4 24 | $528.5M | $34.9M | ||
| Q3 24 | $-124.8M | $33.6M | ||
| Q2 24 | $-199.7M | $40.6M | ||
| Q1 24 | $337.2M | $49.1M |
| Q4 25 | — | 64.6% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 62.7% | ||
| Q1 25 | — | 67.9% | ||
| Q4 24 | -2613.4% | 65.3% | ||
| Q3 24 | -1065.0% | 63.2% | ||
| Q2 24 | -587.6% | 66.4% | ||
| Q1 24 | -289.4% | 67.4% |
| Q4 25 | -11795.9% | 18.4% | ||
| Q3 25 | 18.9% | — | ||
| Q2 25 | — | -7.5% | ||
| Q1 25 | -253.0% | 12.2% | ||
| Q4 24 | — | 16.0% | ||
| Q3 24 | -130.8% | 13.8% | ||
| Q2 24 | -160.1% | 15.0% | ||
| Q1 24 | — | 22.1% |
| Q4 25 | -14298.3% | 12.8% | ||
| Q3 25 | 48.8% | — | ||
| Q2 25 | 338.9% | -5.6% | ||
| Q1 25 | -249.4% | 7.1% | ||
| Q4 24 | 5367.4% | 11.7% | ||
| Q3 24 | -94.8% | 11.6% | ||
| Q2 24 | -137.6% | 13.3% | ||
| Q1 24 | 204.1% | 16.2% |
| Q4 25 | $-4.25 | $0.24 | ||
| Q3 25 | $0.27 | — | ||
| Q2 25 | $1.84 | $-0.11 | ||
| Q1 25 | $-1.55 | $0.14 | ||
| Q4 24 | $1.60 | $0.22 | ||
| Q3 24 | $-0.42 | $0.21 | ||
| Q2 24 | $-0.72 | $0.26 | ||
| Q1 24 | $1.26 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $547.1M | $172.9M |
| Total DebtLower is stronger | $3.6B | $260.0M |
| Stockholders' EquityBook value | $3.5B | $2.0B |
| Total Assets | $7.3B | $2.5B |
| Debt / EquityLower = less leverage | 1.04× | 0.13× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $547.1M | $172.9M | ||
| Q3 25 | $826.4M | — | ||
| Q2 25 | $109.5M | $162.2M | ||
| Q1 25 | $196.2M | $140.7M | ||
| Q4 24 | $391.8M | $177.5M | ||
| Q3 24 | $164.3M | $187.5M | ||
| Q2 24 | $256.0M | $152.9M | ||
| Q1 24 | $324.3M | $145.3M |
| Q4 25 | $3.6B | $260.0M | ||
| Q3 25 | $3.2B | — | ||
| Q2 25 | $2.3B | $346.0M | ||
| Q1 25 | $2.3B | $330.0M | ||
| Q4 24 | $2.4B | $300.0M | ||
| Q3 24 | $618.7M | $300.0M | ||
| Q2 24 | — | $319.0M | ||
| Q1 24 | — | $389.0M |
| Q4 25 | $3.5B | $2.0B | ||
| Q3 25 | $5.2B | — | ||
| Q2 25 | $4.8B | $1.9B | ||
| Q1 25 | $3.7B | $2.0B | ||
| Q4 24 | $4.1B | $2.1B | ||
| Q3 24 | $2.9B | $2.1B | ||
| Q2 24 | $2.6B | $2.1B | ||
| Q1 24 | $2.5B | $2.0B |
| Q4 25 | $7.3B | $2.5B | ||
| Q3 25 | $9.2B | — | ||
| Q2 25 | $7.7B | $2.6B | ||
| Q1 25 | $6.4B | $2.6B | ||
| Q4 24 | $6.8B | $2.7B | ||
| Q3 24 | $3.6B | $2.7B | ||
| Q2 24 | $3.1B | $2.7B | ||
| Q1 24 | $3.0B | $2.7B |
| Q4 25 | 1.04× | 0.13× | ||
| Q3 25 | 0.63× | — | ||
| Q2 25 | 0.47× | 0.18× | ||
| Q1 25 | 0.62× | 0.16× | ||
| Q4 24 | 0.59× | 0.14× | ||
| Q3 24 | 0.22× | 0.14× | ||
| Q2 24 | — | 0.15× | ||
| Q1 24 | — | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-802.7M | — |
| Free Cash FlowOCF − Capex | $-1.2B | — |
| FCF MarginFCF / Revenue | -598.0% | — |
| Capex IntensityCapex / Revenue | 201.2% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-2.0B | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-802.7M | — | ||
| Q3 25 | $-199.0M | — | ||
| Q2 25 | $-163.4M | $98.2M | ||
| Q1 25 | $-215.5M | $41.1M | ||
| Q4 24 | $-677.0M | $84.3M | ||
| Q3 24 | $-160.1M | $63.9M | ||
| Q2 24 | $-115.2M | $75.5M | ||
| Q1 24 | $-88.3M | $81.0M |
| Q4 25 | $-1.2B | — | ||
| Q3 25 | $-283.9M | — | ||
| Q2 25 | $-282.4M | $93.3M | ||
| Q1 25 | $-254.3M | $31.0M | ||
| Q4 24 | $-927.8M | $77.5M | ||
| Q3 24 | $-198.1M | $54.7M | ||
| Q2 24 | $-132.4M | $57.5M | ||
| Q1 24 | $-97.4M | $64.5M |
| Q4 25 | -598.0% | — | ||
| Q3 25 | -112.5% | — | ||
| Q2 25 | -118.4% | 29.4% | ||
| Q1 25 | -118.9% | 9.8% | ||
| Q4 24 | -432.8% | 26.1% | ||
| Q3 24 | -150.5% | 18.9% | ||
| Q2 24 | -91.2% | 18.8% | ||
| Q1 24 | -59.0% | 21.3% |
| Q4 25 | 201.2% | — | ||
| Q3 25 | 33.6% | — | ||
| Q2 25 | 49.9% | 1.5% | ||
| Q1 25 | 18.2% | 3.2% | ||
| Q4 24 | 117.0% | 2.3% | ||
| Q3 24 | 28.9% | 3.2% | ||
| Q2 24 | 11.9% | 5.9% | ||
| Q1 24 | 5.5% | 5.4% |
| Q4 25 | — | — | ||
| Q3 25 | -1.62× | — | ||
| Q2 25 | -0.20× | — | ||
| Q1 25 | — | 1.82× | ||
| Q4 24 | -1.28× | 2.42× | ||
| Q3 24 | — | 1.90× | ||
| Q2 24 | — | 1.86× | ||
| Q1 24 | -0.26× | 1.65× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MARA
Segment breakdown not available.
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
